ClinicalTrials.govpublic full text
A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients
metastatic castration-resistant prostate cancer, abiraterone acetate, prednisone, enzalutamide, cancer, prostate, mdv3100, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 884318
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.